5 Third Avenue Management Collegium Pharmaceutical Trades
Third Avenue Management acquired 203k Collegium Pharmaceutical shares worth $7.98M. That's 1.47% of their equity portfolio (21st largest holding). The stake costed the investor $6.22M, netting the investor a gain of 28% so far.
Avg closing price
Price range
Increased shares by 11.4% (+20.8k shares)
Q4 2024
Avg closing price
$32.92
Price range
$28.61
-
$41.86
Increased shares by 0.2% (+370 shares)
Q3 2024
Avg closing price
$35.66
Price range
$31.40
-
$39.07
Increased shares by 68.6% (+74.2k shares)
Q2 2024
Avg closing price
$34.67
Price range
$31.36
-
$39.99
Increased shares by 30.1% (+25k shares)
Q1 2024
Avg closing price
$34.99
Price range
$31.23
-
$40.91
New holding (+83.1k shares)
Q4 2023
Avg closing price
$25.05
Price range
$21.16
-
$30.80
News about Collegium Pharmaceutical Inc and Third Avenue Management
Brandywine Global Investment Management LLC Boosts Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
¡ Selling at Collegium Pharmaceutical In other Collegium Pharmaceutical news, EVP ¡ stock. Collegium Pharmaceutical Profile (Free Report) Collegium Pharmaceu...
Mutual of America Capital Management LLC Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
¡ year. Collegium Pharmaceutical Profile (Free Report) Collegium Pharmaceutical , Inc, a ¡ specialty pharmaceutical company, develops and ¡ 39; ratings for C...